1. Sneathia: an emerging pathogen in female reproductive disease and adverse perinatal outcomes
- Author
-
Roberto Romero, Andrew D. Winters, Violetta Florova, Andrei B. Borisov, Jose Galaz, Nardhy Gomez-Lopez, and Kevin R. Theis
- Subjects
0301 basic medicine ,Cervical cancer ,business.industry ,030106 microbiology ,General Medicine ,medicine.disease ,Applied Microbiology and Biotechnology ,Microbiology ,Article ,Reproductive disease ,03 medical and health sciences ,Emerging pathogen ,030104 developmental biology ,Immunology ,Medicine ,Bacterial vaginosis ,business - Abstract
Sneathia is an emerging pathogen implicated in adverse reproductive and perinatal outcomes. Although scarce, emerging data suggest that vaginally residing Sneathia becomes pathogenic following its ascension into the upper urogenital tract, amniotic fluid, placenta, and fetal membranes. The role of Sneathia in women’s health and disease is generally underappreciated because the cultivation of these bacteria is limited by their complex nutritional requirements, slow growth patterns, and anaerobic nature. For this reason, molecular methods are typically required for the detection and differential diagnosis of Sneathia infections. Here, we review the laboratory methods used for the diagnosis of Sneathia infections, the molecular mechanisms underlying its virulence, and its sensitivity to antibiotics. We further review the evidence of Sneathia’s contributions to the pathogenesis of bacterial vaginosis, chorioamnionitis, preterm prelabor rupture of membranes, spontaneous preterm labor, stillbirth, maternal and neonatal sepsis, HIV infection, and cervical cancer. Collectively, growing evidence indicates that Sneathia represents an important yet underappreciated pathogen affecting the development and progression of several adverse clinical conditions diagnosed in pregnant and non-pregnant women, as well as in their neonates.
- Published
- 2021